Articles in E-pub version are posted online ahead of regular printed publication.
-
Reviews
Stem cell exosomes: new hope and future potential for relieving liver fibrosis
- Lihua Li, Yongjie Liu, Kunpeng Wang, Jinggang Mo, Zhiyong Weng, Hao Jiang, Chong Jin
- DOI: 10.3350/cmh.2024.0854 [Epub ahead of print]
-
Editorials
Stabilizing Hepatic Fatty Acid Oxidation: USP29 Secures Acyl-CoA Synthesis through ACSL5
- Myeung Gi Choi, Na Young Lee, Ja Hyun Koo
- DOI: 10.3350/cmh.2024.0971 [Epub ahead of print]
-
Replys to Correspondence
Reply to correspondence on “Understanding the impact on digestive disease in the post-COVID-19 condition”
- Yang-Hyun Baek
- DOI: 10.3350/cmh.2024.0966 [Epub ahead of print]
-
Letters to the Editor
Insights on Risk Score Development: Considerations for Early-Stage Hepatocellular Carcinoma Models
- Zhanna Zhang, Gongqiang Wu
- DOI: 10.3350/cmh.2024.0958 [Epub ahead of print]
-
Correspondences
Reply to “Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma”
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- DOI: 10.3350/cmh.2024.0946 [Epub ahead of print]
-
Editorials
A novel clinical trial for primary sclerosing cholangitis from Asia: all regional endeavors should improve global management of PSC
- Atsumasa Komori
- DOI: 10.3350/cmh.2024.0945 [Epub ahead of print]
-
Correspondences
Correspondence on Letter Regarding “Contemporary Awareness of Viral Hepatitis between 2012 and 2022 among Korean Adults”
- Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
- DOI: 10.3350/cmh.2024.0944 [Epub ahead of print]
-
Correspondence on Letter regarding “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
- Moon Haeng Hur, Yoon Jun Kim
- DOI: 10.3350/cmh.2024.0943 [Epub ahead of print]
-
Editorials
Challenges and Innovations in PSC Clinical Trials: Evaluating HK-660S and the Path Forward
- Nilanga Nishad
- DOI: 10.3350/cmh.2024.0942 [Epub ahead of print]
-
Correspondences
Response to the letter
- Hee Yeon Kim, Miyoung Choi, Dae Won Jun
- DOI: 10.3350/cmh.2024.0937 [Epub ahead of print]
-
Reviews
ALCOHOL-ASSOCIATED LIVER DISEASE: NATURAL HISTORY, MANAGEMENT AND NOVEL TARGETED THERAPIES
- Edilmar Alvarado-Tapias, Elisa Pose, Jordi Gratacós, Ana Clemente-Sánchez, Hugo Hugo López-Pelayo, Ramón Bataller
- DOI: 10.3350/cmh.2024.0709 [Epub ahead of print]
-
Correspondences
Correspondence on editorial regarding “Understanding the impact on digestive disease in the post-COVID-19 condition”
- Kwanjoo Lee, Jaeyu Park, Jinseok Lee, Hayeon Lee, Yeonjung Ha, Dong Keon Yon
- DOI: 10.3350/cmh.2024.0935 [Epub ahead of print]
-
Editorials
Stroma-tology: Predicting Recurrence in Cholangiocarcinoma
- Sergi Marco, Chiara Braconi
- DOI: 10.3350/cmh.2024.0932 [Epub ahead of print]
-
Momentum Towards Simplifying and Expanding Treatment for Chronic Hepatitis B: The Body of Evidence Continues to Grow
- Robert J. Wong
- DOI: 10.3350/cmh.2024.0929 [Epub ahead of print]
-
Letters to the Editor
Prevalence of steatotic liver disease and associated fibrosis in the general population: an epidemiological survey
- Lin Guan, Xinhe Zhang, Shanghao Liu, Xiaolong Qi, Yiling Li
- DOI: 10.3350/cmh.2024.0921 [Epub ahead of print]
-
Urgent Need for Education on Hepatocellular Carcinoma Surveillance Among High-Risk Population in China
- Lei Cai, Chao Li, Li-Yang Sun, Yong-Kang Diao, Ming-Da Wang, Tian Yang
- DOI: 10.3350/cmh.2024.0813 [Epub ahead of print]
-
Reviews
Long-term Outcomes and Risk Modifiers of MASLD Between Lean and Non-Lean Populations
- Pojsakorn Danpanichkul, Kanokphong Suparan, Vitchapong Prasitsumrit, Aijaz Ahmed, Karn Wijarnpreecha, Donghee Kim
- DOI: 10.3350/cmh.2024.0631 [Epub ahead of print]
-
Correspondences
Correspondence on letter to the editor regarding “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma”
- Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
- DOI: 10.3350/cmh.2024.0916 [Epub ahead of print]
-
Reviews
Bioactive metabolites: a clue to the link between MASLD and CKD?
- Wen-Ying Chen, Jia-Hui Zhang, Li-Li Chen, Christopher D. Byrne, Giovanni Targher, Liang Luo, Yan Ni, Ming-Hua Zheng, Dan-Qin Sun
- DOI: 10.3350/cmh.2024.0782 [Epub ahead of print]
-
Correspondences
Correspondence on Editorial regarding “Genetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
- Shunda Du, Karin Wisskirchen, Ke Zhang, Ulrike Protzer
- DOI: 10.3350/cmh.2024.0781 [Epub ahead of print]
-
Letters to the Editor
Chronic hepatitis B, Extrahepatic Malignancies and the Use of Antiviral Drugs
- Meng-Che Wu, Shih-Chi Yang, Shuo-Yan Gau
- DOI: 10.3350/cmh.2024.0906 [Epub ahead of print]
-
Snapshots
MODULATION OF LYMPHATIC VESSELS IN MANAGEMENT OF LIVER DISEASE AND COMPLICATIONS
- Aarti Sharma, Pinky Juneja, Shiv K Sarin, Savneet Kaur
- DOI: 10.3350/cmh.2024.0793 [Epub ahead of print]
-
Original Articles
Antiviral Therapy for Chronic Hepatitis B with Mildly Elevated Aminotransferase: A Rollover Study from the TORCH-B Trial
- Yao-Chun Hsu, Chi-Yi Chen, Cheng-Hao Tseng, Chieh-Chang Chen, Teng-Yu Lee, Ming-Jong Bair, Jyh-Jou Chen, Yen-Tsung Huang, I-Wei Chang, Chi-Yang Chang, Chun-Ying Wu, Ming-Shiang Wu, Lein-Ray Mo, Jaw-Town Lin
- DOI: 10.3350/cmh.2024.0640 [Epub ahead of print]
-
Correspondences
Correspondence on Editorial regarding “Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease”
- Young Eun Chon, Jung Hwan Yu, Seung Up Kim
- DOI: 10.3350/cmh.2024.0878 [Epub ahead of print]
-
Reply to: “Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers”
- Satya Priya Sharma, Ki Tae Suk
- DOI: 10.3350/cmh.2024.0872 [Epub ahead of print]
-
Original Articles
Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma
- Yang Liu, Fan Peng, Siyuan Wang, Huanmin Jiao, Kaixiang Zhou, Wenjie Guo, Shanshan Guo, Miao Dang, Huanqin Zhang, Weizheng Zhou, Xu Guo, Jinliang Xing
- DOI: 10.3350/cmh.2024.0527 [Epub ahead of print]
-
Letters to the Editor
Letter regarding “Prevalence of clinically significant liver fibrosis in the general population”
- Wei Feng, Qile Wang, Qingwang Ye
- DOI: 10.3350/cmh.2024.0887 [Epub ahead of print]
-
Replys to Correspondence
Reply: Correspondence: “Transcriptomic signature in hepatocellular carcinoma to predict immunotherapy response.”
- Hiroaki Kanzaki, Yujin Hoshida
- DOI: 10.3350/cmh.2024.0886 [Epub ahead of print]
-
Reply to: Correspondence on Editorial regarding “Genetically modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
- Antonio Bertoletti, Anthony T Tan
- DOI: 10.3350/cmh.2024.0867 [Epub ahead of print]
-
Editorials
Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease
- Won Sohn
- DOI: 10.3350/cmh.2024.0823 [Epub ahead of print]
-
Letters to the Editor
Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma
- Xiping Shen, Ji Wu
- DOI: 10.3350/cmh.2024.0794 [Epub ahead of print]
-
Original Articles
Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments
- Carlos Jose Pirola, Maria Silvina Landa, Mariano Schuman, Silvia Inés García, Adrian Salatino, Silvia Sookoian
- DOI: 10.3350/cmh.2024.0359 [Epub ahead of print]
-
Letters to the Editor
Contemporary Awareness of Viral Hepatitis between 2012 and 2022 among Korean Adults
- Donghee Kim, Won Kim, Aijaz Ahmed
- DOI: 10.3350/cmh.2024.0849 [Epub ahead of print]
-
Editorials
Transient elastography for assessing liver fibrosis in autoimmune liver diseases: Excellent performance but limited details
- Kyung-Ah Kim
- DOI: 10.3350/cmh.2024.0827 [Epub ahead of print]
-
Understanding the impact on digestive disease in the post-COVID-19 condition
- Yang-Hyun Baek
- DOI: 10.3350/cmh.2024.0856 [Epub ahead of print]
-
The Urgent Need for Multidisciplinary Approaches in Managing Alcohol-Associated Liver Disease
- Soon Sun Kim, Jae Youn Cheong
- DOI: 10.3350/cmh.2024.0847 [Epub ahead of print]
-
Correspondences
Correspondence on the Editorial regarding “The use of transient elastography for predicting hepatocellular carcinoma in chronic hepatitis B patients”
- Young-Joo Jin, Seung Up Kim
- DOI: 10.3350/cmh.2024.0846 [Epub ahead of print]
-
Letters to the Editor
Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
- Hang Li, Hua Lu, Xi-Ping Shen, Xiao-Song Li
- DOI: 10.3350/cmh.2024.0832 [Epub ahead of print]
-
Correspondences
Correspondence on Letter regarding “Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors”
- Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Ju-Seog Lee
- DOI: 10.3350/cmh.2024.0830 [Epub ahead of print]
-
Correspondence on Letter regarding “Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response.”
- Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju-Seog Lee
- DOI: 10.3350/cmh.2024.0829 [Epub ahead of print]
-
Original Articles
Self-testing strategy to eliminate Hepatitis C as per WHO’s goal: Analysis of disease burden and cost-effectiveness
- Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn
- DOI: 10.3350/cmh.2024.0484 [Epub ahead of print]
-
Correspondences
Correspondence on Letter regarding “Comprehensive Analysis of Transcriptomic Biomarkers for Predicting Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma.”
- Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Peng Wei, Ju-Seog Lee
- DOI: 10.3350/cmh.2024.0828 [Epub ahead of print]
-
Review Articles
Sinusoidal communication in chronic liver disease
- Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho
- DOI: 10.3350/cmh.2024.0734 [Epub ahead of print]
-
Original Articles
USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination
- Sha Hu, Zhouxiang Wang, Kun Zhu, Hongjie Shi, Fang Qin, Tuo Zhang, Song tian, Yanxiao Ji, Jianqing Zhang, Juanjuan Qin, Zhigang She, Xiaojing Zhang, Peng Zhang, Hongliang Li
- DOI: 10.3350/cmh.2024.0478 [Epub ahead of print]
-
Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
- Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi
- DOI: 10.3350/cmh.2024.0451 [Epub ahead of print]
-
Reviews
Roles of X-box binding protein 1 in liver pathogenesis
- Jihoon Tak, Yun Seok Kim, Sang Geon Kim
- DOI: 10.3350/cmh.2024.0441 [Epub ahead of print]
-
Letters to the Editor
Accountability in AI Medicine: A Critical Appraisal of ChatGPT in Patient Self-Management and Screening
- Jiawen Wang, Tian Xia
- DOI: 10.3350/cmh.2024.0769 [Epub ahead of print]
-
Correspondences
Reply to Letter regarding “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”
- Yuri Cho, Dae Won Jun
- DOI: 10.3350/cmh.2024.0818 [Epub ahead of print]
-
Editorials
The use of transient elastography for predicting hepatocellular carcinoma in chronic hepatitis B patients
- Mirko Zoncapè, Emmanuel A. Tsochatzis
- DOI: 10.3350/cmh.2024.0817 [Epub ahead of print]
-
Correspondences
Correspondence on Editorial regarding “Towards unification of liver stiffness measurement cutoffs”
- Jung Hwan Yu, Seung Up Kim
- DOI: 10.3350/cmh.2024.0815 [Epub ahead of print]
-
Original Articles
Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial
- Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, Gunn Huh, Ce Hwan Park, Sang Hyub Lee, Heon Se Jeong, Hee Jin Kim, Do Hyun Park
- DOI: 10.3350/cmh.2024.0629 [Epub ahead of print]
-
Editorials
HCC surveillance after sustained virological response in chronic hepatitis C
- Ho Soo Chun, Minjong Lee
- DOI: 10.3350/cmh.2024.0795 [Epub ahead of print]
-
Towards unification of liver stiffness measurement cutoffs
- Yangyue Zhang, Vincent Wai-Sun Wong
- DOI: 10.3350/cmh.2024.0766 [Epub ahead of print]
-
Letters to the Editor
Sex-specific associations of metabolic dysfunction-associated steatotic liver disease with cardiovascular outcomes
- Meng-Yuan Miao, Jie-Qiong Lyu, Wei Jiang, Zhong-Yue Liu, Guo-Chong Chen
- DOI: 10.3350/cmh.2024.0719 [Epub ahead of print]
-
Comprehensive Analysis of Transcriptomic Biomarkers for Predicting Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma
- Binghua Li, Jingyuan Wen, Zhu Xu, Peng Yan, Bing Han, Decai Yu
- DOI: 10.3350/cmh.2024.0628 [Epub ahead of print]
-
Letter regarding “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”
- Xiao-Song Li, Xi-Ping Shen, Hang Li
- DOI: 10.3350/cmh.2024.0784 [Epub ahead of print]
-
Correspondences
Correspondence on Editorial regarding “Spotting Undiagnosed Significant Liver Fibrosis in the General Population: Impact on Subsequent Clinical Care”
- Hee Yeon Kim, Miyoung Choi, Dae Won Jun
- DOI: 10.3350/cmh.2024.0777 [Epub ahead of print]
-
Correspondence on Letter regarding “A complement to epigenetics in MASLD”
- Amal Magdy, Hee-Jin Kim, Won Kim, Mirang Kim
- DOI: 10.3350/cmh.2024.0761 [Epub ahead of print]
-
Correspondence on Editorial regarding “KCTD17 as a RAS stabilizer in hepatocellular carcinoma progression”
- Sang Bae Lee, KyeongJin Kim
- DOI: 10.3350/cmh.2024.0750 [Epub ahead of print]
-
PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD
- Baokai Sun, Likun Zhuang
- DOI: 10.3350/cmh.2024.0744 [Epub ahead of print]
-
Editorials
Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors
- Naoshi Nishida
- DOI: 10.3350/cmh.2024.0739 [Epub ahead of print]
-
Spotting Undiagnosed Significant Liver Fibrosis in the General Population: Impact on Subsequent Clinical Care
- Nana Peng, Mary Yue Wang, Sherlot Juan Song, Terry Cheuk-Fung Yip
- DOI: 10.3350/cmh.2024.0737 [Epub ahead of print]
-
Letters to the Editor
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma
- Meng-Che Wu, Hui-Chin Chang, Yi-Sheng Jhang, Shuo-Yan Gau
- DOI: 10.3350/cmh.2024.0682 [Epub ahead of print]
-
Editorials
Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response
- Hiroaki Kanzaki, Yujin Hoshida
- DOI: 10.3350/cmh.2024.0726 [Epub ahead of print]
-
Correspondences
Reply to: “From invasive to intuitive: the emerging role of non-invasive models in hepatic decompensation”
- Chuan Liu, Ling Yang, Hong You, Gao-Jun Teng, Xiaolong Qi
- DOI: 10.3350/cmh.2024.0723 [Epub ahead of print]
-
Editorials
Identification of KCTD17 as a RAS stabilizer in hepatocellular carcinoma
- Rainbow Wing Hei LEUNG, Terence Kin Wah LEE
- DOI: 10.3350/cmh.2024.0718 [Epub ahead of print]
-
Unveiling the distinctive gut microbiota and metabolites in liver cirrhosis and its complications: Novel diagnostic biomarkers
- Soon Kyu Lee, Jong Young Choi
- DOI: 10.3350/cmh.2024.0716 [Epub ahead of print]
-
A complement to epigenetics in MASLD
- Johanna K. DiStefano, Glenn S. Gerhard
- DOI: 10.3350/cmh.2024.0704 [Epub ahead of print]
-
TM6SF2 and PNPLA3: a potential dynamic duo?
- Andrea Caddeo, Rosellina M. Mancina
- DOI: 10.3350/cmh.2024.0703 [Epub ahead of print]
-
From Invasive to Intuitive: The Emerging Role of Non-Invasive Models in Hepatic Decompensation
- Akhil Deshmukh, Rakhi Maiwall
- DOI: 10.3350/cmh.2024.0661 [Epub ahead of print]
-
Correspondences
Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?
- Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
- DOI: 10.3350/cmh.2024.0638 [Epub ahead of print]
-
Review Articles
Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease
- Zobair M. Younossi, Markos Kalligeros, Linda Henry
- DOI: 10.3350/cmh.2024.0431 [Epub ahead of print]
-
Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
- Meng Sha, Jun Wang, Jie Cao, Zhi-Hui Zou, Xiao-ye Qu, Zhi-feng Xi, Chuan Shen, Ying Tong, Jian-jun Zhang, Seogsong Jeong, Qiang Xia
- DOI: 10.3350/cmh.2024.0323 [Epub ahead of print]
-
Editorials
MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors
- Rex Wan-Hin Hui, Lung-Yi Mak
- DOI: 10.3350/cmh.2024.0630 [Epub ahead of print]
-
Letters to the Editor
Presence of liver fibrosis in chronic hepatitis B patients with varying serum HBV DNA levels
- Jian Wang, Shaoqiu Zhang, Chuanwu Zhu, Yuanwang Qiu, Chao Wu, Rui Huang
- DOI: 10.3350/cmh.2024.0602 [Epub ahead of print]
-
Replys to Correspondence
Reply to correspondence regarding “UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma
- Martina Mang Leng LEI, Terence Kin Wah LEE
- DOI: 10.3350/cmh.2024.0621 [Epub ahead of print]
-
Correspondences
Correspondence to letter to the editor on "Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B"
- Gi-Ae Kim, Seung Won Choi, Young-Suk Lim
- DOI: 10.3350/cmh.2024.0619 [Epub ahead of print]
-
Editorials
From Past to Pandemic: Health Disparities in U.S. Hepatobiliary Cancer Mortality Before and During COVID-19
- Ilona Argirion
- DOI: 10.3350/cmh.2024.0597 [Epub ahead of print]
-
Reviews
Precision medicine and nucleotide-based therapeutics to treat MASH
- Andrea Caddeo, Stefano Romeo
- DOI: 10.3350/cmh.2024.0438 [Epub ahead of print]
-
Snapshots
MASLD across women’ reproductive lifespan and issues
- Clara Meda, Arianna Dolce, Sara Della Torre
- DOI: 10.3350/cmh.2024.0419 [Epub ahead of print]
-
Correspondences
Correspondence on Editorial regarding “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
- Renyu Zhang, Ding Wei, Zhinan Chen, Huijie Bian
- DOI: 10.3350/cmh.2024.0590 [Epub ahead of print]
-
Editorials
UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma
- Martina Mang Leng LEI, Terence Kin Wah LEE
- DOI: 10.3350/cmh.2024.0568 [Epub ahead of print]
-
Original Articles
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
- Chuan Liu, Hong You, Qing-Lei Zeng, Yu Jun Wong, Bingqiong Wang, Ivica Grgurevic, Chenghai Liu, Hyung Joon Yim, Wei Gou, Bingtian Dong, Shenghong Ju, Yanan Guo, Qian Yu, Masashi Hirooka, Hirayuki Enomoto, Amr Shaaban Hanafy, Zhujun Cao, Xiemin Dong, Jing LV, Tae Hyung Kim, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Chuanjun Xu, Erhei Dai, Xiaoling Lan, Changxiang Lai, Shirong Liu, Fang Wang, Ying Guo, Jiaojian Lv, Liting Zhang, Yuqing Wang, Qing Xie, Chuxiao Shao, Zhensheng Liu, Liu Ravaioli, Antonio Colecchia, Jie Li, Gao-Jun Teng, Xiaolong Qi
- DOI: 10.3350/cmh.2024.0198 [Epub ahead of print]
-
Reviews
Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
- Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
- DOI: 10.3350/cmh.2024.0246 [Epub ahead of print]